Samalin Investment Counsel, LLC Nkarta, Inc. Transaction History
Samalin Investment Counsel, LLC
- $274 Million
- Q3 2025
A detailed history of Samalin Investment Counsel, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 140,165 shares of NKTX stock, worth $262,108. This represents 0.11% of its overall portfolio holdings.
Number of Shares
140,165
Previous 156,425
10.39%
Holding current value
$262,108
Previous $259,000
11.97%
% of portfolio
0.11%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
58.1MCall Options Held
2MPut Options Held
58.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$20.2 Million0.38% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$13.2 Million0.66% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.59 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.05 Million2.96% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.67 Million0.46% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $91M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...